US · Healthcare

BillionToOne, Inc. Class A Common Stock (BLLN)

Diagnostics & Research

BillionToOne, Inc. Class A Common Stock (BLLN) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BLLN

P/E ratio

18.00

BillionToOne, Inc. Class A Common Stock (BLLN) — FAQ

What is BLLN's P/E ratio?

The price-to-earnings (P/E) ratio for BillionToOne, Inc. Class A Common Stock (BLLN) is 18.00 (data as of 2026-05-23).

Does BillionToOne, Inc. Class A Common Stock pay a dividend?

Dividend yield is not available in the current snapshot for BillionToOne, Inc. Class A Common Stock (BLLN). Check the MyAverix Finance app for the latest dividend data.

What sector is BillionToOne, Inc. Class A Common Stock in?

BillionToOne, Inc. Class A Common Stock (BLLN) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is BLLN listed on?

BLLN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)